Article

SIRT3-Mediated CypD-K166 Deacetylation Alleviates Neuropathic Pain by Improving…

Oxidative Medicine and Cellular Longevity · 2022 · Binbin Yan, author Qiang Liu, author Xiaobao Ding, author Yuwen Lin, author Xiaowei Jiao, author Yuqing Wu, author Huihui Miao, author Chenghua Zhou, author Andreas Daiber, Academic Editor

Key facts

Title SIRT3-Mediated CypD-K166 Deacetylation Alleviates Neuropathic Pain by Improving Mitochondrial Dysfunction and Inhibiting Oxidative Stress
First author Binbin Yan, author Qiang Liu, author Xiaobao Ding, author Yuwen Lin, author Xiaowei Jiao, author Yuqing Wu, author Huihui Miao, author Chenghua Zhou, author Andreas Daiber, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published May 14, 2022
DOI 10.1155/2022/4722647
Product codes mentioned JJQ, JQW

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature